SEC Form 4 · accession 0001615774-17-004227
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George C Carpenter IV
Officer — Chief Executive Officer
Period of report
Aug 8, 2017
Accepted (ET)
Aug 10, 2017 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to purchase)F1,F2 | $6.00 | Aug 8, 2017 | A | 8,000 | A | Aug 8, 2017 | Sep 22, 2026 | Common Stock | 8,000 | 32,000 | D |
Explanation of responses
- F1On September 22, 2016, the reporting person was granted an option to purchase 32,000 shares of common stock. The option vests in four equal installments based on the reporting person's satisfaction of certain performance criteria. As previously reported, the performance criteria for the first, second and third installments were met, resulting in the vesting of the option as to 24,000 shares. On August 8, 2017, the performance criterion for the final installment was met, resulting in the vesting of the option as to the remaining 8,000 shares.
- F2Securities are held in the name of George and Jill Carpenter.